Condition: Solid Tumors · Sponsor: Mirati Therapeutics Inc.
This is an open-label, solid tumor, continuation, rollover trial which enrolls participants from ongoing BMS parent studies that evaluated adagrasib (MRTX849, BMS-986503) either as monotherapy or in combination with other cancer therapies in patients with non-small cell lung cancer (NSCLC), colorectal cancer (CRC) and other advanced solid tumors.
This description comes directly from the study's public registry record.
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com · 855-907-3286 · Clinical.Trials@bms.com
First line of the email MUST contain NCT # and Site #.
Always discuss trial participation with your own doctor first.
| Local Institution - 0005 | Phoenix, Arizona, United States | Withdrawn |
| Southern California Permanente Medical Group | Bellflower, California, United States | Recruiting |
| Local Institution - 0082 | Long Beach, California, United States | Not Yet Recruiting |
| Local Institution - 0003 | Newark, Delaware, United States | Withdrawn |
| Florida Cancer Specialists - North | St. Petersburg, Florida, United States | Recruiting |
| Local Institution - 0112 | Wichita, Kansas, United States | Not Yet Recruiting |
| Local Institution - 0092 | Boston, Massachusetts, United States | Not Yet Recruiting |
| Local Institution - 0080 | Boston, Massachusetts, United States | Not Yet Recruiting |
| Mayo Clinic in Rochester, Minnesota | Rochester, Minnesota, United States | Recruiting |
| Local Institution - 0073 | Saint Paul, Minnesota, United States | Not Yet Recruiting |
| Local Institution - 0036 | Omaha, Nebraska, United States | Not Yet Recruiting |
| Oncology Associates Of Oregon, Pc | Eugene, Oregon, United States | Recruiting |
+ 89 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07415031